Search Results - Leanne de Koning
- Showing 1 - 20 results of 26
- Go to Next Page
-
1
-
2
-
3
NormaCurve: A SuperCurve-Based Method That Simultaneously Quantifies and Normalizes Reverse Phase Protein Array Data by Sylvie Troncale, Aurélie Barbet, Lamine Coulibaly, Émilie Henry, Beilei He, Emmanuel Barillot, Thierry Dubois, Philippe Hupé, Leanne de Koning
Published 2012Artigo -
4
ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels by Sophie Rondeau, Sophie Vacher, Leanne de Koning, Adrien Briaux, Anne Schnitzler, Walid Chemlali, Céline Callens, Rosette Lidereau, Ivan Bièche
Published 2015Artigo -
5
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer by Armelle Corpet, Leanne de Koning, Joern Toedling, Alexia Savignoni, Frédérique Berger, Charlène Lemaître, Roderick J. O’Sullivan, Jan Karlseder, Emmanuel Barillot, Bernard Asselain, Xavier Sastre‐Garau, Geneviève Almouzni
Published 2010Artigo -
6
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer by Didier Meseure, Sophie Vacher, François Lallemand, Kinan Drak Alsibai, Rana Hatem, Walid Chemlali, Nicolás André, Leanne de Koning, Éric Pasmant, Céline Callens, Rosette Lidereau, Antonin Morillon, Ivan Bièche
Published 2016Artigo -
7
Co-occurring Mutations of Tumor Suppressor Genes, <i>LATS2</i> and <i>NF2</i>, in Malignant Pleural Mesothelioma by Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller, Annie Renier, Leanne de Koning, Aurélien de Reyniès, Françoise Le Pimpec‐Barthes, Jessica Zucman‐Rossi, Marie‐Claude Jaurand, Didier Jean
Published 2016Artigo -
8
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report by Rehan Akbani, Karl‐Friedrich Becker, Neil O. Carragher, Ted Goldstein, Leanne de Koning, Ulrike Korf, Lance A. Liotta, Gordon B. Mills, Satoshi Nishizuka, Michael Pawlak, Emanuel F. Petricoin, Harvey B. Pollard, Bryan Serrels, Jingchun Zhu
Published 2014Artigo -
9
The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma by Rocío Montes de, Zachary A. Gurard‐Levin, Frédérique Berger, Haniya Rehman, Elise Martel, Armelle Corpet, Leanne de Koning, Isabelle Vassias, Laurence O.W. Wilson, Didier Meseure, Fabien Reyal, Alexia Savignoni, Bernard Asselain, Xavier Sastre‐Garau, Geneviève Almouzni
Published 2014Artigo -
10
AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin by Christophe Couderc, Alizée Boin, Laetitia Fuhrmann, Anne Vincent‐Salomon, Vinay Mandati, Yann Kieffer, Fatima Mechta‐Grigoriou, Laurence Del Maestro, Philippe Chavrier, David Vallerand, Isabelle Brito, Thierry Dubois, Leanne de Koning, Daniel Bouvard, Daniel Louvard, Alexis Gautreau, Dominique Lallemand
Published 2016Artigo -
11
Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma by Guillaume Carita, Estelle Frisch-Dit-Leitz, Ahmed Dahmani, Chloé Raymondie, Nathalie Cassoux, Sophie Piperno‐Neumann, Fariba Némati, Cécile Laurent, Leanne de Koning, Ensar Halilovic, Sébastien Jeay, Andrew A. Wylie, W. Marston Linehan, Sergio Román-Román, Marie Schoumacher, Didier Decaudin
Published 2016Artigo -
12
Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity <i>In Vitro</i> by Sandra Rebouissou, Tiziana La Bella, Samia Rekik, Sandrine Imbeaud, Anna-Line Calatayud, Nataliya Rohr‐Udilova, Yoann Martin, Gabrielle Couchy, Paulette Bioulac‐Sage, Bettina Grasl‐Kraupp, Leanne de Koning, Nathalie Ganne‐Carrié, Jean‐Charles Nault, Marianne Ziol, Jessica Zucman‐Rossi
Published 2017Artigo -
13
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer by Virginie Maire, Céline Baldeyron, Marion Richardson, Bruno Tesson, Anne Vincent‐Salomon, Eléonore Gravier, Bérengère Marty-Prouvost, Leanne de Koning, Guillem Rigaill, Aurélie Dumont, David Gentien, Emmanuel Barillot, Sergio Román-Román, Stéphane Depil, Francisco Cruzalegui, Alain Pierré, Gordon C. Tucker, Thierry Dubois
Published 2013Artigo -
14
Consensus on precision medicine for metastatic cancers: a report from the MAP conference by Charles Swanton, J.C. Soria, Alberto Bardelli, Andrew V. Biankin, Carlos Caldas, Sarat Chandarlapaty, Leanne de Koning, Caroline Dive, Jean Feunteun, Suet Yi Leung, Richard Marais, Elaine R. Mardis, Nicholas McGranahan, Gary Middleton, Sergio A. Quezada, Jordi Rodón, Nitzan Rosenfeld, C. Sotiriou, Fabrice André
Published 2016Artigo -
15
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020 by Manuel Rodrigues, Leanne de Koning, Sarah E. Coupland, Aart G. Jochemsen, Richard Marais, Marc‐Henri Stern, André Lopes Valente, Raymond L. Barnhill, Nathalie Cassoux, Andrew Evans, Iain Galloway, Martine J. Jager, Ellen Kapiteijn, Bożena Romanowska‐Dixon, Bettina Ryll, Sergio Román-Román, Sophie Piperno‐Neumann
Published 2019Artigo -
16
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers by Florence Coussy, Rania El Botty, Marion Lavigne, Céline Gu, Laetitia Fuhrmann, Adrien Briaux, Leanne de Koning, A. Dahmani, Élodie Montaudon, Ludivine Morisset, Léa Huguet, Laura Sourd, Pierre Painsec, Sophie Château‐Joubert, Thibaut Larcher, Sophie Vacher, Samia Melaabi, Anne Vincent‐Salomon, Elisabetta Marangoni, Ivan Bièche
Published 2020Artigo -
17
Patient‐derived xenografts recapitulate molecular features of human uveal melanomas by Cécile Laurent, David Gentien, Sophie Piperno‐Neumann, Fariba Némati, Nicolás André, Bruno Tesson, Laurence Desjardins, Pascale Mariani, Audrey Rapinat, Xavier Sastre‐Garau, Jérôme Couturier, Philippe Hupé, Leanne de Koning, Thierry Dubois, Sergio Román-Román, Marc‐Henri Stern, Emmanuel Barillot, J. William Harbour, Simon Saule, Didier Decaudin
Published 2013Artigo -
18
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications by Yuna Blum, Clément Meiller, Lisa Quetel, Nabila Elarouci, Mira Ayadi, Danisa Tashtanbaeva, Lucile Armenoult, François Montagne, Robin Tranchant, Annie Renier, Leanne de Koning, Marie‐Christine Copin, Paul Hofman, Véronique Hofman, Henri Porte, Françoise Le Pimpec‐Barthes, Jessica Zucman‐Rossi, Marie‐Claude Jaurand, Aurélien de Reyniès, Didier Jean
Published 2019Artigo -
19
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071 by Sophie Piperno‐Neumann, James Larkin, Richard D. Carvajal, Jason J. Luke, Gary K. Schwartz, F. Stephen Hodi, Marie‐Paule Sablin, Alexander N. Shoushtari, Sebastian Szpakowski, Niladri Roy Chowdhury, A. Rose Brannon, Thiruvamoor Ramkumar, Leanne de Koning, Adnan Derti, W. Marston Linehan, Padmaja Yerramilli-Rao, Ellen Kapiteijn
Published 2020Artigo -
20
Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer by Virginie Maire, Fariba Némati, Marion Richardson, Anne Vincent‐Salomon, Bruno Tesson, Guillem Rigaill, Eléonore Gravier, Bérengère Marty-Prouvost, Leanne de Koning, Guillaume Lang, David Gentien, Aurélie Dumont, Emmanuel Barillot, Elisabetta Marangoni, Didier Decaudin, Sergio Román-Román, Alain St. Pierre, Francisco Cruzalegui, Stéphane Depil, Gordon C. Tucker, Thierry Dubois
Published 2012Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Medicine
Genetics
Cancer
Gene
Internal medicine
Oncology
Breast cancer
Bioinformatics
Computational biology
Signal transduction
Biochemistry
PI3K/AKT/mTOR pathway
Triple-negative breast cancer
Melanoma
Pathology
Apoptosis
Cell biology
Computer science
DNA repair
Gene expression
Cell culture
Cell growth
Chemistry
Chemotherapy
Clinical trial
DNA
DNA damage
Downregulation and upregulation